#1

Type, oral or IM

Results???

#2

Evidence gap

  • Major databases show preclinical mechanistic work on ultrashort peptides and peptide transport, but do not show robust, detailed Cartalax clinical trials with clear mechanisms validated in humans.​
  • As a result, Cartalax’s mechanism must be considered hypothetical and extrapolated from general ultrashort‑peptide biology rather than being clearly established by journal‑published human research.
#3

FWIW…

Today 12/10/2025 ordered 120x capsule and sublingual drops /nasal spray version.

The supplier advertised as the original Cartalax Khavinson Peptide product from Russia.

1 Like
#4

Keep us updated. I’ve been interested in these bioregulator peptides.